n6-2′-o-dibutyryl-adenosine 3′,5′-cyclophosphate sodium salt monohydrate
Date:2021-12-24 Categories:Related Application Product
| post date: |
dec 24,2021 |
| expiry date: |
jun 22,2022 |
| detailed description: |
cas no. :16980-89-5
|
| cas registry number: |
16980-89-5
|
| synonyms: |
;poly i-poly c;bucladesine sodium salt;adenosine, n-(1-oxobutyl)-, cyclic 3′,5′-(hydrogen phosphate)-2′-butanoate, monosodium salt;bucladesine sodium;dt 5621 sodium salt;dibutyl camp sodium salt;dibutyl cyclic amp sodium;dibutyl cyclic amp sodium salt;monosodium dibutyryl cyclic amp;sodium dibutyryl 3′,5′-cyclic amp;sodium dibutyryl camp;sodium dibutyryl cyclic adenosine-3′,5′-monophosphate;adenosine, n-(1-oxobutyl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butanoate, monosodium salt;butyramide, n-(9-beta-d-ribofuranosyl-9h-purin-6-yl)-, cyclic hydrogen phosphate, butyrate (ester), monosodium salt;sodium (4ar,6r,7r,7ar)-6-[6-(butanoylamino)-9h-purin-9-yl]-7-(butanoyloxy)tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide;n-6,o-2′-dibutyryladenosine cyclic 3′,5′-monophosphate sodium salt; |
| molecular formula: |
c18h23n5nao8p |
| molecular weight: |
491.3675 |
| molecular structure: |
|